Chemotherapy improves survival for patients with lymph node-negative invasive papillary breast cancer with tumors ≥2 cm: a SEER population-based study
For patients with LN-negative IPC with tumor ≥ 2.0 cm and patients with grade III or undifferentiated disease, chemotherapy significantly improved OS. Future randomized controlled trials are expected to validate the results.
Authors
- Yi-Zi Zheng (ORCID: https://orcid.org/0000-0002-3847-8494)
- Tingting Wu (ORCID: https://orcid.org/0000-0002-7836-6040)
- Jia-Qi Ying
- Ai-Na Zheng
- Zhuo-Zhao Zhan
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Shenzhen Second People's Hospital (CN)
- Eindhoven University of Technology (NL)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1093/oncolo/oyaf422
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Wenzhou Municipal Science and Technology Bureau